This week's round-up of new financings in the biotech world is headed by a big round for Third Arc, a specialist in T-cell engager antibodies, with Autobahn, Brenig, Confo, and GRO Bio also in on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results